Astrego receives the Bona Postulata prize

Open positions

Astrego is accelerating product development activities in Uppsala.


Astrego’s disruptive technology makes it possible to capture individual bacterial cells from complex samples and measure their growth rate in real-time. This enables the fastest possible Antibiotic Susceptibility Test (AST).


Products targeting a wide range of microbiological applications, designed to enable evidence-based prescription of antibiotics and help reduce the spread of antimicrobial resistance (AMR).


Astrego Diagnostics is a rapidly growing in vitro diagnostic company based in Uppsala, Sweden. Our team combines multidisciplinary scientific excellence with seasoned diagnostic industry management.

This website use cookies.
By using the website you consent to this.
Read more here.